EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Agonism of FFA4/GPR120 activates tyrosine hydroxylase and confers neuroprotection from 6-OHDA-induced cytotoxicity in PC12 cells and in a rat 6-OHDA model of Parkinson’s disease

Farnoosh Moghaddam, Monika Binwal, Andrea J Green, Kalyn M Rambacher, Bo Jarrett Wood, Kevin S Murnane, Nader H Moniri

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.117685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Farnoosh Moghaddam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, GA 30341, USA. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Oxidopamine, Tyrosine 3-Monooxygenase, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institutes of Health, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Free-fatty acid receptor 4 (FFA4/GPR120), a G-protein-coupled receptor activated by medium to long-chain free-fatty acids (FFA) including ω-3 polyunsaturated fatty acids, regulates many metabolic and anti-inflammatory processes, and has also been linked to diverse neurophysiological functions. Here, we investigated the expression and functional role of FFA4 in dopaminergic systems using PC12 cells, rat striatal tissue, and an in vivo 6-hydroxydopamine (6-OHDA) model of Parkinson's disease (PD). FFA4 mRNA and protein were expressed in rat caudate-putamen and colocalized with tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis. Agonism of FFA4 by the endogenous agonist docosahexaenoic acid (DHA) or the selective synthetic agonist TUG-891 significantly increased phosphorylation of TH-Ser40 in PC12 cells and rat striatal minces, without elevating cAMP, suggesting non-canonical signaling of FFA4 to TH. In PC12 cells, TUG-891 attenuated 6-OHDA-induced cytotoxicity in a concentration-dependent manner, concomitant with reductions in reactive oxygen species (ROS) generation and NF-κB transcriptional activity, effects that were reversed by the FFA4 antagonist AH-7614. In an in vivo rat 6-OHDA model of PD, TUG-891 administration significantly mitigated apomorphine-induced rotational asymmetry and motor deficits in 6-OHDA-lesioned rats, while preserving striatal TH immunoreactivity. These findings identify FFA4 as a novel modulator of dopaminergic neuron integrity that may operate through antioxidant and anti-inflammatory signals to preserve cell function, warranting further exploration of FFA4 in dopaminergic degeneration and PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledOxidopamineTyrosine 3-MonooxygenaseNeuroprotective AgentsNeuroprotectionAnimalsPC12 CellsRatsMaleRats, Sprague-DawleyDocosahexaenoic AcidsBiphenyl CompoundsCell SurvivalPhenylpropionates

Stichwörter der Autor:innen

DopamineFFA4Free-fatty acidsGPR120Parkinson’s diseaseTyrosine hydroxylase

Substanzen

Receptors, G-Protein-CoupledOxidopamineTyrosine 3-MonooxygenaseFfar4 protein, ratNeuroprotective Agents3-(4-((4-fluoro-4'-methyl-(1,1'-biphenyl)-2-yl)methoxy)phenyl)propanoic acidDocosahexaenoic AcidsBiphenyl CompoundsPhenylpropionates

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, GA 30341, USA.
  • Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
  • Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA; Louisiana Addiction Research Center, Louisiana State University Health S…
  • Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, GA 30341, USA; Department of Biomedical Sciences, School of Medicine, Mercer University H…

Förderung

  • NINDS NIH HHS
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Moghaddam, F., Binwal, M., Green, A. J., Rambacher, K. M., Wood, B. J., Murnane, K. S., & Moniri, N. H. (2026). Agonism of FFA4/GPR120 activates tyrosine hydroxylase and confers neuroprotection from 6-OHDA-induced cytotoxicity in PC12 cells and in a rat 6-OHDA model of Parkinson’s disease. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.117685

Vancouver

Moghaddam F, Binwal M, Green AJ, Rambacher KM, Wood BJ, Murnane KS, et al. Agonism of FFA4/GPR120 activates tyrosine hydroxylase and confers neuroprotection from 6-OHDA-induced cytotoxicity in PC12 cells and in a rat 6-OHDA model of Parkinson’s disease. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.117685

BibTeX
@article{Moghaddam2026,
  author = {Moghaddam, Farnoosh and Binwal, Monika and Green, Andrea J and Rambacher, Kalyn M and Wood, Bo Jarrett and Murnane, Kevin S and Moniri, Nader H},
  title = {Agonism of FFA4/GPR120 activates tyrosine hydroxylase and confers neuroprotection from 6-OHDA-induced cytotoxicity in PC12 cells and in a rat 6-OHDA model of Parkinson’s disease},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.117685}
}
Kostenlos starten →